DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with…

Overview of attention for article published in Respiratory Research, October 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

So far, Altmetric has seen 1 news story.

DESTINATION Phase III extension trial demonstrates sustained long-term safety and efficacy of Tezspire compared to placebo…